Skip to main content

ATOH7 293T Cell Transient Overexpression Lysate

Novus Biologicals, part of Bio-Techne | Catalog # H00220202-T02

Discontinued Product
H00220202-T02 has been discontinued. View all ATOH7 products.

Key Product Details

Species

Human

Applications

Western Blot

Product Summary for ATOH7 293T Cell Transient Overexpression Lysate

Quality control test: Transient overexpression cell lysate was tested with Anti-IQGAP3 antibody by Western Blots. Plasmid: pCMV-ATOH7 full-length

Product Specifications

Specificity

ATOH7 293T Cell Transient Overexpression Lysate(Denatured)

Type

293T Cell Transient Overexpression

Protein State

Denatured

Formulation, Preparation, and Storage

Formulation

1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)

Concentration

mg/ml

Shipping

The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.

Storage

Store at -80C. Avoid freeze-thaw cycles.

Background: ATOH7

ATOH7 is a member of the family of basic helix-loop-helix (bHLH) proteins with similarity to Drosophila'atonal,' a proneural bHLH gene that controls photoreceptor development (Brown et al., 2002 (PubMed11889557)).(supplied by OMIM)

Alternate Names

ATH5, atonal homolog 7 (Drosophila), BHLHA13, bHLHa13protein atonal homolog 7, Class A basic helix-loop-helix protein 13, hATH5, Helix-loop-helix protein hATH-5, Math5

Gene Symbol

ATOH7

Additional ATOH7 Products

Product Documents for ATOH7 293T Cell Transient Overexpression Lysate

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ATOH7 293T Cell Transient Overexpression Lysate

This product is produced by and distributed for Abnova, a company based in Taiwan.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Lysates are guaranteed for 6 months from date of receipt.

Loading...
Loading...
Loading...
Loading...